To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Obesity

Interventions

DRUG

AZD2820

Ascending subcutaneous injections of AZD2820 once daily for 14 days in the abdomen

DRUG

Placebo

Ascending subcutaneous injections of placebo for AZD2820 once daily for 14 days in the abdomen

Trial Locations (1)

Research site, London